KBI Biopharma Inc. — Form D

KBI Biopharma Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2009-09-23. The offering totals $10.0M, of which $9.6M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2009-09-23
• Form: D
• Accession: 0001314013-09-000004
• Industry: Biotechnology
• Exemptions: 06
• Total offering: $10.0M
• Amount sold: $9.6M
• Remaining: $400K
• Minimum investment: $10K
• Investors: 9
• Date of first sale: 2009-08-14
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-72839

Issuer

• Name: KBI Biopharma Inc.
• CIK: 0001314013
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 1101 HAMLIN RD, DURHAM, NC, 27704
• Phone: 919-479-9898

Officers, directors & promoters (7)

More

• CIK 1314013 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search